Back to News
investment

Up 50% in One Year: Why a Fund Cut $5 Million in TriMas Stock but Held Onto a 3% Position

newsfeedback@fool.com (Jonathan Ponciano)
Loading...
4 min read
0 likes
⚡ Quantum Brief
Barington Companies Management sold 143,900 shares of TriMas (TRS) in Q4 2025, valued at $5.02 million, per a February 12, 2026 SEC filing, reducing its position amid a 51.4% stock surge over the past year. Despite the $5.98 million quarterly position decline—combining trades and price shifts—the fund retained a 3.05% stake, signaling strategic rebalancing rather than a full exit from the outperforming industrial stock. TriMas reported Q3 2025 sales up 17.4% YoY to $269.3 million, with aerospace revenue soaring 45.8%, driving a 33.9% adjusted operating profit increase and quadrupled free cash flow to $43.9 million. The company’s diversified portfolio—spanning packaging, aerospace fasteners, and industrial components—supports resilience, with full-year EPS guidance raised to $2.02–$2.12, reflecting sustained momentum. Within Barington’s top holdings, TriMas remains a tactical 3% allocation, offering cyclical aerospace and industrial exposure alongside dominant consumer-retail stocks like Macy’s and Victoria’s Secret.
AI Audio Summary
0:00 / 0:00
Click to play
growtika-TKAg3WignSw-unsplash.jpg
Quantum News · Media Library

TriMas Corporation designs and manufactures engineered components for global packaging, aerospace, and industrial markets.On February 12, 2026, Barington Companies Management reported selling 143,900 shares of TriMas (TRS +1.46%), an estimated $5.02 million trade based on quarterly average pricing, according to a new SEC filing.What happenedIn a quarterly disclosure filed with the U.S. Securities and Exchange Commission on February 12, 2026, Barington Companies Management reported selling 143,900 shares of TriMas in the fourth quarter of 2025. The estimated transaction value, based on the period’s average unadjusted closing price, was $5.02 million. The value of the fund's TriMas position fell by $5.98 million over the quarter, a figure that includes both trading activity and market price movement.What else to knowFollowing the sale, TriMas represents 3.05% of the fund’s reported U.S. equity assets under management.Top holdings after the filing:NYSE: M: $28.66 million (18.8% of AUM)NASDAQ: MATW: $26.12 million (17.1% of AUM)NYSE: VSCO: $23.02 million (15.1% of AUM)NYSE: BILL: $21.27 million (14.0% of AUM)NYSE: GIL: $15.94 million (10.5% of AUM)As of February 12, 2026, shares of TriMas were priced at $35.75, up 51.4% over the past year and well outperforming the S&P 500 by 38.45 percentage points.Company overviewMetricValueRevenue (TTM)$1.01 billionNet income (TTM)$44.08 millionDividend yield0.45%Price (as of market close February 12, 2026)$35.75Company snapshotTriMas provides dispensing products, closures, fasteners, aerospace components, steel cylinders, and industrial equipment across its Packaging, Aerospace, and Specialty Products segments.The company generates revenue primarily through the design, manufacture, and sale of proprietary and custom-engineered products for consumer, industrial, and aerospace applications.Key customers include consumer product companies, aerospace original equipment manufacturers and suppliers, industrial distributors, and commercial end-users worldwide.TriMas is a diversified manufacturer with a global presence, serving multiple end markets through specialized product lines. Its strategy emphasizes innovation in packaging and aerospace fasteners, leveraging established brands and engineering expertise to address evolving customer needs. The company’s broad product portfolio and focus on operational efficiency support a competitive position in the packaging and industrial components sectors.What this transaction means for investorsWhen a cyclical industrial stock climbs more than 50% in a year, trimming exposure can look like discipline rather than doubt.TriMas recently posted $269.3 million in third quarter sales, up 17.4% year over year, with adjusted diluted EPS rising 41.9% to $0.61. Aerospace was the standout, with sales surging 45.8% as build rates and new awards drove operating leverage. Adjusted operating profit increased 33.9% to $30.3 million, and year-to-date free cash flow reached $43.9 million, nearly quadrupling the prior year period. Management raised full-year adjusted EPS guidance to a range of $2.02 to $2.12, signaling confidence into year end.Within a portfolio dominated by consumer and retail names like Macy’s, Victoria’s Secret, and BILL, TriMas adds exposure to aerospace and industrial recovery, and at 3.05% of assets, it is meaningful but not oversized. For long-term investors, the key is sustainability. Aerospace momentum looks durable, but margins must hold once growth normalizes. TriMas reports fourth-quarter earnings on February 26.About the AuthorJonathan Ponciano is a contributing stock market analyst at The Motley Fool. He has nearly a decade of experience as a financial journalist, most recently as an editor and senior reporter at Forbes focused on markets, technology, and entrepreneurship. Jonathan has also written for Investopedia and the Los Angeles Business Journal. He holds a dual B.A. in Business Journalism and Economics from the University of North Carolina at Chapel Hill and an M.B.A. from Columbia Business School. A North Carolina native now based in New York City, Jonathan has also lived in Mexico City and Los Angeles.CMFjonponcStocks MentionedTriMasNASDAQ: TRS$36.27 (+1.46%) $+0.52*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Read Original

Tags

aerospace-defense
quantum-investment

Source Information

Source: The Motley Fool

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.